Evidence map›Paper›PMID 42338614›Full record

ReviewUS cardiology2026

Diagnostic Approach to Left Ventricular Hypertrophy: A Review.

Sukriti Banthiya, Ankit Agrawal, Devesh Rai, Medhat Chowdhury, Stephen Pan, Srihari S Naidu

Abstract readReview
In one paragraph

Review in US cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sukriti BanthiyaDepartment of Cardiovascular Disease, Henry Ford Providence Southfield, MI.
Ankit AgrawalDepartment of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic Cleveland, OH.
Devesh RaiDepartment of Cardiovascular Disease, Sands-Constellation Heart Institute, Rochester Regional Health Rochester, NY.
Medhat ChowdhuryDepartment of Cardiovascular Disease, Henry Ford Providence Southfield, MI.
Stephen PanDepartment of Cardiology, Westchester Medical Center Valhalla, NY.ORCID https://orcid.org/0000-0002-1189-4199
Srihari S NaiduDepartment of Cardiology, Westchester Medical Center Valhalla, NY.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Left ventricular hypertrophy (LVH) is a not uncommon finding on cardiac imaging, seen in 10-20% of adults. LVH can represent a response to a physiological load on the heart (either by athletic training, hypertension, or structural heart issues) or it can represent a primary pathology (e.g. infiltrative disorders, including cardiac amyloidosis and sarcoidosis) or familial/genetic conditions (e.g. hypertrophic cardiomyopathy). LVH is an independent risk factor for adverse cardiovascular events, regardless of its etiology. In this review, we survey the etiologies, clinical approach, and use of multimodality imaging in those with LVH.

Indexed as

aortic stenosisathlete’s heartcardiac amyloidosiscardiac sarcoidosisHypertrophic cardiomyopathyinfiltrative cardiomyopathyleft ventricular hypertrophy

Identifiers

PMID42338614
PMCPMC13284792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.